Literature DB >> 17687491

A transient three-plasmid expression system for the production of hepatocytes targeting retroviral vectors.

Peng Qi1, Jinxiang Han, Yanqin Lu, Chuanxi Wang, Bo Zhu.   

Abstract

Targeting of retroviral vectors to specific cells was attempted through modifying the surface protein of the murine leukemia viruses (MLVs), but in many cases the protein function was affected, and it is difficult to achieve the targeted delivery. In this study, we have tried to engineer ecotropic Moloney murine leukemia viruses (MoMLV)-based retroviral vectors to transduce hepatocytes. A chimeric envelope (Env) expression plasmid was constructed containing the hepatitis B virus PreS2 peptide fused to aa +1 at the N-terminus of Env. Following simultaneous transfection of pgag-pol, pLEGFP and chimeric env plasmids into 293T cells, helper-free retrovirus stocks with the titer of approximately 10(4) infectious units/ml were achieved at 48 h post-transfection. These pseudotype vectors showed the normal host range of retrovirus, infecting host NIH 3T3 cells, although the efficiency was reduced compared with that of virions carrying wild-type ecotropic MoMLV envelope. In addition, the resultant pseudotype viruses could transduce human hepatoma cells mediated by polymerized human serum albumin with relatively high titers in comparison with those transductions without polymerized human serum albumin. This approach can be used to target hepatocytes selectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17687491     DOI: 10.1111/j.1745-7270.2007.00318.x

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  2 in total

1.  Efficient inhibition of hepatitis B virus replication by hepatitis delta virus ribozymes delivered by targeting retrovirus.

Authors:  Chuan-Xi Wang; Yan-Qin Lu; Peng Qi; Long-Hua Chen; Jin-Xiang Han
Journal:  Virol J       Date:  2010-03-17       Impact factor: 4.099

Review 2.  The Evolution of Gene Therapy in the Treatment of Metabolic Liver Diseases.

Authors:  Carlos G Moscoso; Clifford J Steer
Journal:  Genes (Basel)       Date:  2020-08-10       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.